SCHEMBL20692131

SCHEMBL20692131

N#CCCOP(OCC1CC(n2cnc3c(Cl)ncnc32)C1)O[C@@H]1C(CO)OC(n2ccc3c(Cl)ncnc32)C1F

nearest known ligand 0.36

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
▸ SLC29A1 Q99808 8/20 0.35
▸ TYMP P19971 1/20 0.33
▸ METTL3 Q86U44 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22349173 0.76 TYMP (0.33) SLC29A1TYMPMETTL3
SCHEMBL20692127 0.76 TYMP (0.33) SLC29A1TYMPMETTL3
SCHEMBL20691971 0.73 ADCY5 (0.35) TYMP
SCHEMBL24680688 0.68 NT5E (0.42) —
SCHEMBL10060036 0.66 METTL3 (0.55) SLC29A1METTL3
SCHEMBL10079496 0.66 METTL3 (0.55) SLC29A1METTL3
SCHEMBL15948784 0.66 METTL3 (0.55) SLC29A1METTL3
SCHEMBL1689454 0.66 METTL3 (0.55) SLC29A1METTL3
SCHEMBL1689451 0.66 METTL3 (0.55) SLC29A1METTL3
SCHEMBL20691937 0.66 P2RY1 (0.36) TYMP

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3658565-B1 CYCLIC DINUCLEOTIDES AS ANTICANCER AGENTS BRISTOL MYERS SQUIBB CO (US) 2022-11-09 — — EP disclosed
WO-2019023459-A1 CYCLIC DINUCLEOTIDES AS ANTICANCER AGENTS BRISTOL-MYERS SQUIBB COMPANY (US) 2019-01-31 — — WO disclosed
Send feedback